IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.482
NA - Nord America 409
EU - Europa 212
SA - Sud America 11
AF - Africa 6
OC - Oceania 6
Totale 4.126
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.134
US - Stati Uniti d'America 393
CN - Cina 209
HK - Hong Kong 114
GB - Regno Unito 58
IT - Italia 45
DE - Germania 35
FI - Finlandia 17
CZ - Repubblica Ceca 15
NL - Olanda 15
CA - Canada 10
FR - Francia 8
IN - India 8
TR - Turchia 8
BR - Brasile 7
PL - Polonia 7
AU - Australia 5
ES - Italia 5
MX - Messico 5
ZA - Sudafrica 4
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
JP - Giappone 2
PE - Perù 2
UA - Ucraina 2
AZ - Azerbaigian 1
BE - Belgio 1
CY - Cipro 1
GN - Guinea 1
HT - Haiti 1
JO - Giordania 1
KI - Kiribati 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
SA - Arabia Saudita 1
Totale 4.126
Salva come PNG Salva come JPEG
Città #
Singapore 118
Hong Kong 112
Hefei 103
Ashburn 91
Boardman 55
London 48
Beijing 44
Shanghai 36
Munich 25
Rome 20
Los Angeles 16
Brno 15
Council Bluffs 15
Dallas 15
Seattle 15
San Francisco 13
Amsterdam 10
West Jordan 10
Santa Clara 9
Turku 9
Boston 8
Helsinki 8
New York 8
São Paulo 7
Washington 7
Pune 6
Warsaw 6
Sona 5
Toronto 5
Guangzhou 4
Mexico City 4
Brooklyn 3
Chicago 3
Johannesburg 3
Montreal 3
Paris 3
Secaucus 3
Stockholm 3
Boydton 2
Camden 2
Canberra 2
Central 2
Lima 2
Manchester 2
Melbourne 2
Naples 2
Suffern 2
Tokyo 2
Zhengzhou 2
Almere Stad 1
Amman 1
Ankara 1
Atlanta 1
Augusta 1
Brussels 1
Buffalo 1
Carney 1
Changchun 1
Chennai 1
Cleveland 1
Cold Lake 1
Conakry 1
Delmas 1
Foligno 1
Frankfurt am Main 1
Fuzhou 1
Gauteng 1
Genoa 1
Handan 1
Hangzhou 1
Hanover 1
Helena 1
Hengshui 1
Jinan 1
Las Vegas 1
Milan 1
Nanyang 1
Newark 1
Nicosia 1
Oklahoma City 1
Orem 1
Philadelphia 1
Phoenix 1
Pingxiang 1
Poplar 1
Providence 1
Rabat 1
Riyadh 1
Rockville 1
Salt Lake City 1
Shenzhen 1
Slough 1
Stow 1
Sydney 1
Tarawa 1
The Dalles 1
Tianjin 1
Trieste 1
Wuxi 1
Xingtai 1
Totale 941
Salva come PNG Salva come JPEG
Nome #
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 198
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 198
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 197
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 195
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 195
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 191
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 186
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 185
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 184
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 184
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 179
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 176
Assessment of liver function by the exhaled breath-print during chronic liver disease 169
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 168
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 128
Diabetes in chronic liver disease: from old concepts to new evidence 100
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 96
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 86
A challenging alfa-fetoprotein in a cirrhotic patient 85
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 84
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 84
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 83
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 79
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 73
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 56
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 34
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 34
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 31
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 31
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 31
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 27
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 26
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 25
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 25
Hepatic complications of bariatric surgery : the reverse side of the coin 24
Surgical complications after resection of adrenal carcinoma 23
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 23
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 23
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 22
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 20
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 20
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 19
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 19
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 19
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 18
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 17
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 17
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 15
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 14
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 14
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 13
Totale 4.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 4 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/2026262 169 81 12 0 0 0 0 0 0 0 0 0
Totale 4.143